Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper

EPMA Journal

Vincenzo Costigliola²  Judita Kinkorova¹  Olga Golubnitschaja³ 

[1] Technology Centre Academy of Sciences, Prague 165 02, Czech Republic;The European Medical Association, 1160 Brussels, Belgium;The European Association for Predictive, Preventive and Personalised Medicine, 1150 Brussels, Belgium

关键词: Education;    Ethics;    Economy;    Integrative bioinformatics;    Health care;    Industrial leadership;    Societal challenges;    Excellent science and technological innovation;    Horizon 2020;    Preventive and Personalised Medicine;    Predictive;   

Others  :  800948
DOI  :  10.1186/1878-5085-5-6

 received in 2014-02-28, accepted in 2014-03-17,  发布年份 2014

【 摘 要 】

The European Association for Predictive, Preventive and Personalised Medicine (EPMA) considers acute problems in medical sciences as well as the quality and management of medical services challenging health care systems in Europe and worldwide. This actuality has motivated the representatives of EPMA to comment on the efforts in promoting an integrative approach based on multidisciplinary expertise to advance health care-related research and management. The current paper provides a global overview of the problems related to medical services: pandemic scenario in the progression of common non-communicable diseases, delayed interventional approaches of reactive medicine, poor economy of health care systems, lack of specialised educational programmes, problematic ethical aspects of several treatments as well as inadequate communication among professional groups and policymakers. In the form of individual paragraphs, the article presents a consolidated position of PPPM professionals towards the new European programme ‘Horizon 2020’ providing the long-lasting instruments for scientific and technological progress in medical services and health care-related programmes. In the author's opinion, Horizon 2020 provides unlimited room for research and implementation in Predictive, Preventive and Personalised Medicine. However, the overall success of the programme strongly depends on the effective communication and consolidation of professionals relevant for PPPM as well as the communication quality with policymakers. Smart political decision is the prerequisite of the effective PPPM implementation in the health care sector. This position is focused on the patients' needs, innovative medical sciences, optimal health and disease management, expert recommendations for the relevant medical fields and optimal solutions which have a potential to advance health care services if the long-term strategies were to be effectively implemented as proposed here.

【 授权许可】

   
2014 Golubnitschaja et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

Figure 11.

Figure 12.

Figure 13.

Figure 14.

Figure 15.

Figure 16.

Figure 17.

Figure 18.

Figure 19.

Figure 20.

Figure 21.

Figure 22.

Figure 23.

Figure 24.

Figure 25.

【 参考文献 】

• [1]Advances in Predictive, Preventive and Personalised Medicine [http://www.springer.com/series/10051 webcite]
• [2]Golubnitschaja O: Time for new guidelines in advanced diabetes care: paradigm change from delayed interventional approach to predictive, preventive & personalized medicine. EPMA J 2010, 1:3-12.
• [3]Norstedt I: Horizon 2020: European perspectives in healthcare sciences and implementation. EPMA J 2014, 5:A1. BioMed Central Full Text
• [4]Golubnitschaja O, Swanton C, Danesi R, Costigliola V: Promoting predictive, preventive and personalised medicine: European event of global importance. EPMA J 2011, 2:131-136.
• [5]Golubnitschaja O, Costigliola V, EPMA: General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J 2012, 1(1):14.
• [6]EPMA Summit and World Congress 2013 in Brussels: European Association for Predictive, Preventive and Personalised Medicine develops a new culture in communication amongst stakeholders [http://www.epmanet.eu/images/stories/pdfs/EPMA%20Summit%20and%20World%20Congress%202013_press%20release_Oct%202013.pdf webcite]
• [7]The EU Framework Programme for Research and Innovation - health, demographic change and wellbeing [http://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing webcite]
• [8]The EU Framework Programme for Research and Innovation - What is Horizon 2010? [http://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020 webcite]
• [9]Innovation Unit - a Europe 2020 Initiative [http://ec.europa.eu/research/innovation-union/index_en.cfm webcite]
• [10]Golubnitschaja O, Yeghiazaryan K: Opinion controversy to chromium picolinate therapy's safety and efficacy: ignoring “anecdotes” of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics? EPMA J 2012, 3:11. BioMed Central Full Text
• [11]Golubnitschaja O: Three levels of prediction, prevention & individualised treatment algorithms to advance diabetes care: integrative approach. In New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM. Edited by Mozaffari MS. Dordrecht, Heidelberg, New York, London: Springer; 2013:15-28. ISBN 978-94-007-5970-1
• [12]Golubnitschaja O: Diabetes mellitus. In Predictive Diagnostics and Personalized Treatment: Dream or Reality?. Edited by Golubnitschaja O. New York: Nova Science; 2009. 147–150, ISBN 978-1-60692-737-3
• [13]Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, Kuhn W, Schild HH: Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? EPMA J 2013, 4:6. BioMed Central Full Text
• [14]Golubnitschaja O, Yeghiazaryan K, Cebioglu M, Morelli M, Herrera-Marschitz M: Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care. EPMA J 2011, 2:197-210.
• [15]Yeghiazaryan K, Flammer J, Golubnitschaja O: Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J 2010, 1:263-272.
• [16]Golubnitschaja O, Yeghiazaryan K, Flammer J: Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible? EPMA J 2010, 1:237-244.
• [17]Yeghiazaryan K, Flammer J, Golubnitschaja O: Individual predispositions in healthy vasospastic individuals: patient profiling for targeted prevention of “down-stream” pathologies as cost-effective personalised medicine. In Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future. Edited by Mandel S. Dordrecht, Heidelberg, New York, London: Springer; 2013:13-29. ISBN 978-94-007-5865-0
• [18]Golubnitschaja O, Yeghiazaryan K, Wunderlich K, Schild HH, Flammer J: Disease proteomics reveals altered basic gene expression regulation in leukocytes of normal-tension and primary open-angle glaucoma patients. Proteomics Clin Appl 2007, 1:1316-1323.
• [19]Golubnitschaja O: Neurodegeneration: accelerated ageing or inadequate healthcare? EPMA J 2010, 1:211-215.
• [20]Golubnitschaja O, Watson ID, Topic E, Sandberg S, Ferrari M, Costigliola V: Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care. EPMA J 2013, 4:12. BioMed Central Full Text
• [21]HORIZON 2020 - WORK PROGRAMME 2014 – 2015 [http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/main/h2020-wp1415-health_en.pdf webcite]
• [22]Research & Innovation - Horizon 2020 Funding [https://ec.europa.eu/research/participants/portal/desktop/en/home.html webcite]
• [23]Costigliola V, Gahan P, Golubnitschaja O: Predictive medicine as the new philosophy in health care. In Predictive Diagnostics and Personalized Treatment: Dream or Reality. Edited by Golubnitschaja O. New York: Nova Science; 2009:1-3. ISBN 978-1-60692-737-3
• [24]Golubnitschaja O: Changing long-held beliefs is never easy: a proposal for multimodal approaches in female healthcare - an integrative view. In Healthcare Overview: New Perspectives. Edited by Costigliola V. Dordrecht, Heidelberg, New York, London: Springer; 2012:251-268. ISBN 978-94-007-4602-2
• [25]Costigliola V: Mobility of medical doctors as an attribute of the cross-border healthcare: challenges, opportunities and perspectives. In Healthcare Overview: New Perspectives. Edited by Costigliola V. Dordrecht, Heidelberg, New York, London: Springer; 2012:233-244. ISBN 978-94-007-4602-2
• [26]Carlsen S, Petersen PH, Skeie S, Skadberg Ø, Sandberg S: Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med 2011, 49:1501-1507.
• [27]Kapalla M, Matuskova D: Information systems as an essential component of prediction in the laboratory diagnostics. In Predictive Diagnostics and Personalized Treatment: Dream or Reality. Edited by Golubnitschaja O. New York: Nova Science; 2009:529-548.
• [28]Mandel S, Golubnitschaja O: Time for new guidelines in handling of neurodegenerative disorders: optimistic versus pessimistic prognosis by application of PPPM. In Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future. Edited by Mandel S. Dordrecht, Heidelberg, New York, London: Springer; 2013:3-9.
• [29]Shapira N: A gender-specific nutritional approach to women's healthcare. In Healthcare Overview: New Perspectives. Edited by Costigliola V. Dordrecht, Heidelberg, New York, London: Springer; 2012:269-305.
• [30]Marcus-Kalish M: Simultaneous systematic approach to enable predictive, preventive and personalised medicine - women healthcare as a case study. In Healthcare Overview: New Perspectives. Edited by Costigliola V. Dordrecht, Heidelberg, New York, London: Springer; 2012:313-331.
• [31]Drucker E, Krapfenbauer K: Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J 2013, 4:7. BioMed Central Full Text
• [32]Kapalla M: Healthcare information complexity and the role of informatics in predictive, preventive and personalized medicine. In Personalisierte Medizin. Edited by Niederlag W, Lemke HU, Golubnitschaja O, Rienhoff O. Dresden: Health Academy; 2010:83-108.
• [33]Gefenas E, Cekanauskaite A, Tuzaite E, Dranseika V, Characiejus D: New Ethical Paradigm in Preventive, Predictive and Personalised Medicine. In Healthcare Overview: New Perspectives. Edited by Costigliola V. Dordrecht, Heidelberg, New York, London: Springer; 2012:471-484. ISBN 978-94-007-4602-2
• [34]Society for Participatory Medicine [http://participatorymedicine.org/ webcite]
• [35]The EPMA Journal [http://www.epmajournal.com/ webcite]